Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Free Cash Flow: 2020-2025

Historic Free Cash Flow for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $36.6 million.

  • Cellebrite DI's Free Cash Flow fell 15.82% to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.1 million, marking a year-over-year increase of 40.34%. This contributed to the annual value of $123.6 million for FY2024, which is 27.66% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Free Cash Flow is $36.6 million, which was up 1.11% from $36.2 million recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Free Cash Flow peaked at $69.1 million during Q4 2024, and registered a low of -$8.2 million during Q1 2022.
  • Moreover, its 3-year median value for Free Cash Flow was $30.3 million (2023), whereas its average is $31.3 million.
  • As far as peak fluctuations go, Cellebrite DI's Free Cash Flow slumped by 795.27% in 2022, and later spiked by 2,717.50% in 2023.
  • Over the past 5 years, Cellebrite DI's Free Cash Flow (Quarterly) stood at $30.6 million in 2021, then rose by 21.47% to $37.1 million in 2022, then climbed by 24.11% to $46.1 million in 2023, then skyrocketed by 50.03% to $69.1 million in 2024, then dropped by 15.82% to $36.6 million in 2025.
  • Its Free Cash Flow was $36.6 million in Q3 2025, compared to $36.2 million in Q2 2025 and $23.2 million in Q1 2025.